FDA Adverse Event Injury Summary report: N

GYNECARE TVT SECUR SYSTEM

MDR report key: 3252283 · Received July 29, 2013

Report

Report Number
2210968-2013-14892
Event Type
Injury
Date Received
July 29, 2013
Report Date
July 17, 2013
Manufacturer
ETHICON INC.
Product Code
PAH
PMA / PMN Number
K052401
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). CONCLUSION: NO CONCLUSION CAN BE DRAWN AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE OBTAINED, A SUPPLEMENTAL 3500A FORM WILL BE SUBMITTED ACCORDINGLY.

Additional Manufacturer Narrative · 1

(B)(4)

Additional Manufacturer Narrative · 1

(B)(4). IT WAS REPORTED THAT THE PATIENT UNDERWENT A GYNECOLOGICAL PROCEDURE AND MESH WAS IMPLANTED ALONG WITH CONCURRENT VAGINAL VAULT SUSPENSION, CYSTOCELE REPAIR WITH GRAFT, SUB-URETHRAL SLING, LAPAROSCOPIC SIGMOID COLON RESECTION, RECTOPEXY, ENTEROCELE, RECTOCELE, ANAL SPHINCTER REPAIR, AND CYSTOURETHROSCOPY DUE TO URODYNAMIC STRESS INCONTINENCE, STAGE III UTERINE PROLAPSE, AND STAGE III ANTERIOR COMPARTMENT PROLAPSE. IT WAS REPORTED THAT THE PATIENT UNDERWENT A GYNECOLOGICAL PROCEDURE AND MESH WAS IMPLANTED ON (B)(6) 2007 ALONG WITH A LAPAROSCOPIC SUPRACERVICAL HYSTERECTOMY, BSO, COLPOPEXY AND CYSTO DUE VAGINAL PROLAPSE. IT WAS REPORTED THAT FOLLOWING INSERTION THE PATIENT EXPERIENCED PAIN, EXTRUSION, INFECTION, URINARY/BOWEL PROBLEMS, FISTULAE, RECURRENCE, BLEEDING, DYSPAREUNIA, NEUROMUSCULAR PROBLEMS AND VAGINAL SCARRING.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT UNDERWENT A GYNECOLOGICAL PROCEDURE ON (B)(6) 2007 AND MESH AND SURGISIS ES SOFT TISSUE GRAFT WERE IMPLANTED. THE PATIENT EXPERIENCED PAIN, EROSION OF INTERNAL TISSUES, AND HAS UNDERGONE ADDITIONAL SURGERIES AND REVISIONARY PROCEDURES. NO ADDITIONAL INFORMATION IS PROVIDED AT THIS TIME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
351678 GYNECARE TVT SECUR SYSTEM MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC PAH ETHICON INC. UNK UNK

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention